Clinical Intelligence Global Market Report 2025

The clinical intelligence market size has grown rapidly in recent years. It will grow from $7.91 billion in 2024 to $9.11 billion in 2025 at a compound annual growth rate (CAGR) of 15.2%. The growth during the historic period is attributed to the increasing adoption of electronic health records, rising demand for data-driven decision making, growing healthcare data volumes, expansion of healthcare IT infrastructure, and heightened focus on improving patient outcomes.

The clinical intelligence market size is expected to see rapid growth in the next few years. It will grow to $15.61 billion in 2029 at a compound annual growth rate (CAGR) of 14.4%. The growth in the forecast period can be attributed to increasing emphasis on personalized medicine, rising demand for real-time clinical insights, expansion of telehealth and remote monitoring, and growing government support for healthcare digitalization. Key trends in the forecast period include advancements in artificial intelligence and machine learning, innovations in natural language processing, development of cloud-based clinical intelligence platforms, integration of blockchain for secure data sharing, and increasing research and development in clinical analytics.

The rising use of electronic health records drove the growth of the clinical intelligence market during the historic period. Electronic health records are digital versions of patient medical histories maintained over time, containing detailed health information such as diagnoses, treatments, medications, and test results accessible to authorized healthcare providers. The growth of electronic health records is driven by digital transformation in healthcare, improving data accessibility and coordination among providers to enhance patient outcomes. Clinical intelligence complements electronic health records by analyzing large volumes of patient data to generate actionable insights, helping healthcare providers make data-driven decisions that improve care quality and efficiency. For instance, in June 2023, the UK Parliament reported that by December 2023, 90 percent of NHS trusts had implemented electronic health records, with full adoption achieved by March 2025. Therefore, increasing electronic health record adoption supported the growth of the clinical intelligence market.

Major companies in the clinical intelligence market are developing AI-driven solutions such as digital triage to enhance patient assessment, streamline workflows, and improve clinical decision-making. Digital triage uses AI-powered tools to assess patient symptoms, prioritize care, and direct patients to the appropriate clinical pathway efficiently. In July 2025, Experity Inc., a US-based software and services company, launched Care Agent, the first clinical intelligence solution designed for urgent care. The platform uses AI and integrates with electronic medical records to improve clinic operations and patient engagement. It enables secure web chat and SMS communication, providing a personalized, HIPAA-compliant experience without extra apps. Its modular features include digital discharge delivery, lab results communication, and planned enhancements such as triage assessments and appointment reminders.

In January 2023, Det Norske Veritas (DNV), a Norway-based risk management and assurance company, acquired Medicare Beneficiary Identifier (MBI) for an undisclosed sum. DNV aims to strengthen its presence in the digital health sector by leveraging MBI Healthcare Technologies’ AI-driven data assurance solutions to improve patient safety, optimize care efficiency, and reduce errors in electronic health records. Medicare Beneficiary Identifier (MBI) is a UK-based company that delivers clinical intelligence through AI-backed technology and data quality expertise.

Major companies operating in the clinical intelligence market are Microsoft Corporation, Alphabet Inc. (Google LLC), Amazon Web Services (AWS), Optum (UnitedHealth Group), International Business Machines (IBM) Corporation, IQVIA, GE Healthcare Technologies, Inc., Koninklijke Philips N.V., Medtronic Plc, Medidata, AvoMD, Zebra Medical Vision, Teledoc Health, Health Catalyst, Tempus, PathAI, Biofourmis, Twin Health, BenevolentAI, Prometheus Biosciences, Abridge, Owkin, Insitro, Heidi Health, Pieces Technologies, Renalytix PLC, OpenEvidence, Bayesian Health, and SmarterDx.

North America was the largest region in the clinical intelligence market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the clinical intelligence market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the clinical intelligence market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The clinical intelligence market research report is one of a series of new reports that provides clinical intelligence market statistics, including clinical intelligence industry global market size, regional shares, competitors with a clinical intelligence market share, detailed clinical intelligence market segments, market trends and opportunities, and any further data you may need to thrive in the clinical intelligence industry. This clinical intelligence market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Clinical intelligence involves the use of advanced data analytics and information systems to collect, analyze, and interpret healthcare data from multiple sources including electronic health records, lab results, and patient monitoring systems. Its main goal is to provide actionable insights that help healthcare providers enhance patient outcomes, optimize clinical workflows, and make informed decisions in medical care.

The main components of clinical intelligence are software, hardware, and services. Software includes data analytics and decision-support platforms that collect, integrate, and analyze clinical data to improve patient outcomes, optimize workflows, and support evidence-based decision-making in healthcare. It leverages technologies such as artificial intelligence, machine learning, natural language processing, predictive analytics, business intelligence, and data mining, and is deployed through both on-premise and cloud-based models. Applications include predictive analytics, clinical decision support, population health management, performance management, reporting and dashboards, and risk management. End-users include hospitals, diagnostic centers, ambulatory care centers, research institutes, and pharmaceutical and biotechnology companies.

The clinical intelligence market consists of revenues earned by entities by providing services such as data collection and integration, healthcare analytics, patient monitoring, and reporting and visualization. The market value includes the value of related goods sold by the service provider or included within the service offering. The clinical intelligence market also includes sales of clinical data analytics software, healthcare dashboards, reporting tools, and electronic health record (EHR) integration solutions. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.